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Brugada  syndrome  (BrS)  is  one  of  the  most  common  inher-
ited  arrhythmogenic  disorders,  with  a  worldwide  prevalence
of  approximately  0.05%.  It  is  characterized  by  a  typical  elec-
trocardiographic  pattern  (ST-segment  elevation  with  coved
morphology  in  the  right  precordial  leads  and  right  bundle
branch  block)  combined  with  malignant  ventricular  arrhyth-
mias  (MVA),  that  can  lead  to  syncope  or  sudden  cardiac  death
(SCD).1,2 This  electrocardiographic  pattern  is  intermittent
and  may  be  unmasked  by  fever  or  pharmacological  chal-
lenge  with  intravenous  sodium  channel  blockers,  of  which
flecainide  or  ajmaline  are  most  often  used.
It  is  accepted  that  an  implantable  cardioverter-
defibrillator  (ICD)  should  be  used  in  patients  with  aborted
SCD,  arrhythmia-related  syncope  or  MVA.3 However,  there  is
still  a  lack  of  consensus  on  the  management  of  asymptomatic
patients  with  BrS.  Accurate  identification  of  subjects  at  high
risk  of  SCD  is  a  major  challenge  in  the  clinical  management
of  BrS.
A  spontaneous  type  1  Brugada  electrocardiogram  (ECG),
inducible  ventricular  arrhythmias  on  electrophysiological
study,  syncope  and  family  history  of  SCD  have  been  reported
as  independent  predictors  of  significant  ventricular  arrhyth-





0870-2551/© 2020 Sociedade Portuguesa de Cardiologia. Published by E
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)CN5A  gene,  which  encodes  the  cardiac  sodium  channel,  is
inked  to  BrS,  with  mutations  identified  in  around  one  out
f  four  patients.2 SCN5A  mutations  appear  to  contribute
o  the  occurrence  of  events,  but  most  genetic  findings
n  BrS  are  variants  of  unknown  significance,  and  caution
hould  be  exercised  when  translating  them  into  clinical  risk
tratification.6
In  2006,  Castro  et  al.,  in  a  small  study  with  BrS  patients,
howed  that  a  long  corrected  QT  (QTc)  interval  in  lead  V2
>460  ms)  and  a  long  interval  from  the  peak  to  the  end  of  the
 wave  (Tpeak-Tend)  were  associated  with  the  occurrence
f  MVA  in  long-term  follow-up.7 It  is  well  known  that  long  QT
nterval  is  associated  with  increased  vulnerability  to  ventric-
lar  tachyarrhythmias,  and  spatial  transmural  dispersion  of
epolarization  may  be  an  underlying  mechanism  contributing
o  the  occurrence  of  MVA  in  BrS.  In  recent  years,  Tpeak-Tend
nterval,  Tpeak-Tend/QT  ratio  and  Tpeak-Tend  dispersion
ave  been  suggested  as  electrocardiographic  variables  that
an  quantify  transmural  dispersion  of  repolarization.8
The  retrospective  study  by  Bravo  et  al.  published  in  this
ssue  of  the  Journal,  assessed  the  role  of  QTc  >460  ms  in
ultiple  ECGs  as  a  marker  of  MVA  recurrence  during  a  very
ong  follow-up  after  ICD  implantation  in  BrS  patients.9 Their
esults  showed  that  the  group  with  prolonged  QT  on  at  least
wo  ECGs  (group  3)  had  more  ventricular  tachycardia  or  ven-
ricular  fibrillation  events  detected  by  the  ICD  than  patients
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ith  no  long  QT  (group  1)  or  with  only  one  ECG  with  QTc
460  ms  (group  2),  with  differences  in  Kaplan-Meier  survival
urves  observed  immediately  following  ICD  placement.
The  data  presented  reveal  that  group  1  patients  were
lso  those  with  the  highest  rate  of  spontaneous  type  1  ECG,
amily  history  of  SCD,  previous  cardiac  arrest,  syncope  and
revious  documented  MVA.  Thus,  according  to  the  state  of
he  art,  they  were  already  considered  to  be  at  high  risk
ased  on  available  clinical  variables.  It  should  also  be  borne
n  mind  that  groups  2  and  3  included  only  seven  and  nine
atients,  respectively.
Another  issue  concerns  the  wide  variability  of  QT  inter-
als.  Even  in  patients  with  at  least  one  ECG  showing  QTc
460  ms  during  follow-up,  prolonged  QT  was  present  in  only
9%  of  the  ECGs  performed.  Of  course,  significant  intra-  and
nterobserver  variability  of  manual  QT  measurements  would
e  expected,  but  it  is  accepted  that  cardiac  autonomic
one,  circadian  dynamics,  respiration,  age,  gender,  certain
rugs,10 and  possibly  the  intermittent  presence  or  absence
f  the  typical  ST  elevation  or  abnormal  QRS  fragmentation
nd  early  repolarization  pattern,  may  influence  QT  inter-
al  duration.  Some  of  these  variables  could  help  explain  the
ide  variations  obtained  in  QT  interval  measurements.
The  inclusion  of  other  electrocardiographic  markers  of
ransmural  dispersion  of  repolarization,  such  as  Tpeak-Tend
nterval,  Tpeak-Tend/QT  ratio  and  Tpeak-Tend  dispersion,
ould  potentially  contribute  to  understanding  the  observed
ariability  in  repolarization  phenomena.
Interestingly,  programmed  electrical  stimulation,  per-
ormed  in  80%  of  the  population,  did  not  predict  the
ecurrence  of  MVA  events,  which  is  in  agreement  with  pre-
ious  studies  on  BrS,  showing  that  the  use  of  this  technique
s  still  a  controversial  issue  in  risk  stratification.11,12
Finally,  in  this  study  most  patients  (>80%)  were  symp-
omatic.  It  would  be  of  interest  to  include  asymptomatic
rS  patients,  a  large  group  for  whom  risk  stratification
ecisions  pose  great  challenges,  when  assessing  the  repro-
ucibility  of  these  results.  The  indication  to  implant  an  ICD
emains  a  source  of  debate  in  asymptomatic  subjects  with
n  ECG  pattern  compatible  with  BrS.  Further  investigation
s  therefore  required  to  acquire  a  comprehensive  physiolog-
cal  understanding  of  the  dynamic  mechanisms  underlying
he  occurrence  of  spontaneous  MVA  in  BrS,  in  order  to  obtain
linical  benefits  in  the  management  of  this  population,  who
re  frequently  young  and  without  symptoms.onflicts of interest
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